MiR-365 overexpression leads to a decrease in the proliferation rate and formation of clones of human ovarian cancer cells, as well as inhibition of angiogenesis and suppression of VEGF, Ang-1 and MMP-2 expression [64]. This evidence concerns the gene VEGFA and ovarian carcinoma.